Hims & Hers Health (HIMS): Officer filed to sell ~$442K
Autor Deborah M., Officer at Hims & Hers Health, filed to sell ~$442K of Hims & Hers Health shares.
- ~$442K
- planned to sell · 24K shares, around Nov 17, 2026
- Planned for
- Nov 17, 2026
- Notice filed
- Nov 17, 2026
What stands out in this filing
- The planned sale is 0.01% of the company's shares outstanding, as stated on the notice.
- How the shares were acquired, per the notice: Restricted Stock Vesting.
- The notice says the shares were received as pay (stock awards or options).
- Broker named on the notice: Fidelity Brokerage Services LLC.
- A Form 144 announces a sale; the Form 4 that follows shows whether it took place, at what price.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Sep 17, 2026InsiderCFO sold ~$355K of HIMS shares in the open market
- Sep 22, 2026InsiderCFO sold ~$877K of HIMS shares in the open market
- Sep 30, 2026InsiderOfficer sold ~$101K of HIMS shares in the open market
- Oct 1, 2026InsiderCFO sold ~$59K of HIMS shares in the open market
- Oct 7, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 5, 2026, Jonathan M. Franklin commenced employment with Hims & Hers Health, Inc. (the “Company”) as chief accounting officer. On October 7, 2026, the Company's board of directors appointed Mr. Franklin as principal accounting officer of the Company, effective October 9, 2026, concurrently with the previously disclosed resignation of Irene Becklund as the Company's principal accounting officer.”
- Oct 14, 2026InsiderOfficer sold ~$101K of HIMS shares in the open market
- Oct 28, 2026InsiderOfficer sold ~$96K of HIMS shares in the open market
- Oct 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 5.0%
- Nov 4, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 4, 2026, the board of directors (the “Board”) of Hims & Hers Health, Inc. (the “Company”) increased the size of the Board from nine to ten directors and appointed Dr. Andrew Huberman, 51, to fill the newly created directorship, effective immediately.”
- Nov 9, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
- Nov 16, 20265% stakeG1 Execution Services, LLC reported a passive stake (13G) of 4.8%
- Nov 17, 2026Insider · 3 peopleInsiders: 3 sales (~$571K)
How to read SEC Form 144
Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.
Full guide: What is an SEC Form 144?
What else is on file for Hims & Hers Health
For Hims & Hers Health, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HIMS page.
How this filing works
Explore the data
Common questions
Which Hims & Hers Health (HIMS) insider traded, and how much?
Autor Deborah M., Officer at Hims & Hers Health, filed to sell ~$442K of Hims & Hers Health shares. 24K shares, Form 144 notice of a planned sale.
When did it happen, and when was it made public?
Planned for: Nov 17, 2026. Notice filed: Nov 17, 2026.
What stands out in this filing?
The planned sale is 0.01% of the company's shares outstanding, as stated on the notice. How the shares were acquired, per the notice: Restricted Stock Vesting. The notice says the shares were received as pay (stock awards or options).
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 144, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Hims & Hers Health recently?
For Hims & Hers Health, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days. They are listed on the HIMS page.
Does this mean HIMS stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Hims & Hers Health
- SEC Form 4Nov 18, 2026
- SEC Form 4Nov 18, 2026
- SEC Form 4Nov 18, 2026
- SEC Form 144Nov 17, 2026
- SEC Form 144Nov 17, 2026
- SEC Form 13F-HRNov 16, 2026
Everything OQRO holds on this company is on its HIMS page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
